Donald Wuchterl has been promoted to chief operating officer at Cytovance Biologics. Mr. Wuchterl will oversee Cytovance’s R&D services, manufacturing and warehouse, facilities, engineering, and program management functions. Mr. Wuchterl joined the company in July of 2012 as senior vice president of manufacturing operations. 

Mr. Wuchterl has played a major leadership role in organizational improvements and Cytovance’s growth and expansion. This includes the construction and qualification/validation of several new production suites as well as a new Greenfield manufacturing and GMP warehousing facility that will greatly increase the company’s scale, service offerings, and technical capabilities.

“I have had the distinct pleasure of knowing Don for many years and feel he is the ideal candidate for this position. His knowledge and experience with both clinical and commercial biologics manufacturing, along with his years of working in the design and validation of biologics facilities makes him an invaluable asset to Cytovance’s Leadership team,” said chief executive officer Darren Head.